Ledger.Open graph →
SEC Form D · filed January 17, 2020

EvolveImmune Therapeutics Holding Company, LLC

Offering
$35.1M
Sold
$17.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WESTPORT, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Alessandra Di Bacco · Cambridge, MADirectorStephen Bloch · Westport, CTExecDenis Patrick · New City, NYDirectorSteven Hurwitz · Pikesville, MDExecJason W. Lettmann · Menlo Park, CADirectorHugo Beekman · Germantown, MDDirectorChris P. Galvin · Bayport, MNExecSeth Wolkov · Denver, CODirectorHugo Beekman · Gaithersburg, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗